Meeting
2017 ASCO Annual Meeting
TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33 / AGO‐OVAR OP7).
Authors
Sven Mahner
Department for Gynecology and Obstetrics, University of Munich, Munich, Germany
Sven Mahner , Florian Heitz , Alexander Burges , Alexander Reuss , Bernhard Kraemer , Barbara Schmalfeldt , Jalid Sehouli , Bjoern Lampe , Andreas Schnelzer , Pauline Wimberger , Christina Fotopoulou , Frederic Guyon , Fabrice Lecuru , Denis Querleu , Stefano Greggi , Nicoletta Colombo , Giovanni Damiano Aletti , Philipp Harter , Andreas Du Bois
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Clinical Trial Registration Number
NCT02828618
Citation
J Clin Oncol 35, 2017 (suppl; abstr TPS5602)
DOI
10.1200/JCO.2017.35.15_suppl.TPS5602
Abstract #
TPS5602
Poster Bd #
423a
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Does aggressive surgery only benefit patients with less advanced ovarian cancer?
First Author: Shinichi Tate
First Author: Jennifer Taylor Veneris
First Author: Larissa Meyer
Poster
2023 ASCO Annual Meeting
BRCA1 and RAD51 methylation impact on outcome in patients with advanced ovarian cancer: A PAOLA-1 ancillary study.
First Author: Helene Blons